Today

Agents

Chat

Arena

Discover

More

App

Recursion Pharma CEO Najat Khan sells 22,408 shares for $78,822 - RXRX News | Rallies

Recursion Pharma CEO Najat Khan sells 22,408 shares for $78,822

RXRX•2026-09-10

CEO share sale disclosed

Recursion Pharmaceuticals CEO and President Najat Khan sold 22,408 Class A common shares on Sep. 8, 2026.
Sale priced at USD 3.52 per share, based on a weighted average across multiple trades.
Directly held stake fell to 2,072,890 shares following the transaction.

Related News

Apple SVP, GC Jennifer Newstead sells 1,438 shares for $456,576.74

AAPL•2026-09-10

Global Markets-Wall Street dips after US wholesale inflation data, oil climbs

SPY•2026-09-10

Zoom director Santiago Subotovsky disposes of Zoom common shares worth $254,738

Sources

S

Recursion Pharma CEO Najat Khan sells 22,408 shares for $78,822

Sec

•

2026-09-10

Capital Southwest Corporation Prices Public Offering Of $350 Million 6.750% Notes Due 2031

CSWC•2026-09-10

Rum Group - Tether To Exchange Northern Data Shares For 2.0281 Rum Class A Common Stock Per Share

RUM•2026-09-10